Combination therapy in systemic mycosis.
Polak
A
A
Pharmaceutical Research F. Hoffmann-La Roche, Ltd. Basel, Switzerland.
D000666:Amphotericin B / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology; D003453:Cryptococcosis / Q000188:drug therapy*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D009181:Mycoses / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D011446:Prospective Studies; D012293:Rifampin / Q000627:therapeutic use
D000666:Amphotericin B; D005437:Flucytosine; D012293:Rifampin